You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 280 No. 1, July 1, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  This Week in JAMA
 This Article
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

This Week in JAMA

JAMA. 1998;280:3.

HIV/AIDS Theme Issue
Include a Protease Inhibitor in Multidrug Regimen

State-of-the-art treatment dictates that physicians strongly consider including a protease inhibitor in a multidrug regimen when initiating treatment for HIV infection. In this study of simultaneous vs sequential treatment in patients followed for at least 100 weeks, Dr Gulick and colleagues found that those who received a regimen with a simultaneously initiated protease inhibitor showed better immunologic status and virologic profile.

(SEE ARTICLE)


New Test Could Mean Improved Treatment Planning

Discussing prognosis and treatment options with a patient newly diagnosed with HIV infection would benefit from an accurate estimate of infection duration. The modified ELISA test described by Dr Janssen and colleagues may provide more precision in defining disease history in an individual, allowing physicians to plan more appropriate treatment strategies.

(SEE ARTICLE)


Heterosexual Spread of HIV in Southeast Asia

The spread of HIV in Southeast Asia often appears to involve transmission to spouses from men having sex with infected female sex workers. However, in this study of HIV prevalence and risk factors in Thai women in the prenatal care setting, Dr Siriwasin and colleagues found that about one fourth of the sex partners of seropositive women were not HIV-infected.

(SEE ARTICLE)


Delivery Method and Perinatal HIV Transmission

Even though prophylaxis with zidovudine significantly reduces the rate of perinatal HIV transmission, there remains a substantial risk for transmitting HIV to the infant. In this study of pregnant women with HIV infection who received zidovudine prophylaxis, Dr Mandelbrot and colleagues observed an attenuated risk of perinatal HIV transmission with elective cesarean delivery.

(SEE ARTICLE)


Why a Genital Lesion Increases HIV Transmission Risk

The presence of a genital lesion increases the risk of transmitting HIV to a sex partner. Dr Schacker and colleagues evaluated 12 HIV-1–seropositive men with genital herpes lesions. HIV-1 was recovered from lesions in 25 of 26 episodes of genital herpes and on 67% of days, and was more likely to be recovered from lesions on days when HSV-2 also was recovered.

(SEE ARTICLE)


Latest Recommendations for Antiretroviral Therapy

In this consensus statement, the International AIDS Society–USA Panel provides state-of-the-art recommendations for potent antiretroviral therapy, including considerations for changing or modifying therapy and strategies for such special circumstances as HIV infection in pregnancy.

(SEE ARTICLE)


The Cover

A Cover Without Art.

(SEE ARTICLE)


Medical News & Perspectives

The FDA has approved the first wide-scale testing of a vaccine to prevent AIDS, although some scientists remain skeptical about its prospects for success.

(SEE ARTICLE)


Contempo 1998

Most pediatric HIV-1 infections are acquired perinatally. Effective strategies for prevention of vertical transmission of HIV-1 are emerging.

(SEE ARTICLE)


A Piece of My Mind

"Often we do not acknowledge the gift our patients offer when they become involved in research." From "Success and Sadness."

(SEE ARTICLE)


Controversies

Treat now or later? Early and aggressive vs delayed and conservative therapy in early HIV infection.

(SEE ARTICLE)


JAMA Patient Page

For your patients: drug treatment options for HIV infection.

(SEE ARTICLE)







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.